Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
1976-12-1
|
pubmed:language |
ger
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0440-0607
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
18
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
329-38
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:964711-Adult,
pubmed-meshheading:964711-BCG Vaccine,
pubmed-meshheading:964711-Female,
pubmed-meshheading:964711-Germany, East,
pubmed-meshheading:964711-Hodgkin Disease,
pubmed-meshheading:964711-Humans,
pubmed-meshheading:964711-Lymphoma,
pubmed-meshheading:964711-Male,
pubmed-meshheading:964711-Middle Aged,
pubmed-meshheading:964711-Remission, Spontaneous,
pubmed-meshheading:964711-Time Factors
|
pubmed:year |
1976
|
pubmed:articleTitle |
[Activation of the immune system and remission period in malignant lymphomas].
|
pubmed:publicationType |
Journal Article
|